Skip to content

Effect of DU meridian Acupuncture and Temporal Triangular Therapy on Vascular Protection Mechanisms in Patients with Acute Cerebral Infarction: A Randomized Controlled Evaluator-Blinded Clinical Trial

Effect of DU meridian Acupuncture and Temporal Triangular Therapy on Vascular Protection Mechanisms in Patients with Acute Cerebral Infarction: A Randomized Controlled Evaluator-Blinded Clinical Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2024000508
Enrollment
Unknown
Registered
2024-10-01
Start date
2024-10-11
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Cerebral Infarction

Interventions

experimental group:Acupuncture

Sponsors

First Clinical Medical College of Guangzhou University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1)Meets the diagnostic criteria for acute cerebral infarction in the "Guidelines for the Prevention and Treatment of Stroke in China" (2021 edition), and is diagnosed through head CT or MR examination; (2)Meets the diagnostic criteria for stroke in traditional Chinese medicine; (3)Individuals who have had their first stroke within 7 days of onset and are aged between 35 and 75 years old; (4)NIHSS score = 3 and = 20, and there was no physical disability related to this study before the onset of the disease; (5)Clear consciousness (GCS = 13 points); (6)Those who voluntarily participate in this study and sign an informed consent form.

Exclusion criteria

Exclusion criteria: (1)Transient ischemic attacks, subarachnoid hemorrhage, cerebral hemorrhage, etc; (2)Patients who require arterial or venous thrombolysis or thrombectomy due to their condition; (3)Suffering from diseases related to the immune system, such as acute or chronic infections, tumors, and blood diseases; Severe organ dysfunction: (4)Individuals with severe impairment of cardiovascular function, upper gastrointestinal bleeding, or intolerance to electroacupuncture, or those equipped with pacemakers or stents; (5)Pregnant or preparing pregnant or lactating patients; (6)Family members or patients with poor initiative and lack of cooperation; (7)Participants in other clinical trials within one month.

Design outcomes

Primary

MeasureTime frame
National Institutes of Health Stroke Scale NIHSS;

Secondary

MeasureTime frame
CD14+;TNF-a;Modified Barthel IndexMBI;Modified Rankin ScalemRS;VEGF;

Countries

China

Contacts

Public ContactHe Jun

First Clinical Medical College of Guangzhou University of Chinese Medicine

895150145@qq.com13728020800

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026